Allelic modification of breast cancer risk in women with an NBN mutation-Reference-Cited by-同舟云学术

Allelic modification of breast cancer risk in women with an NBN mutation

Published:2019-08-13 Issue:2 Volume:178 Page:427-431
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Rusak Bogna, ,Kluźniak Wojciech,Wokołorczyk Dominika,Stempa Klaudia,Kashyap Aniruddh,Rudnicka Helena,Gronwald Jacek,Huzarski Tomasz,Dębniak Tadeusz,Jakubowska Anna,Szwiec Marek,Akbari Mohammad R.,Narod Steven A.,Lubiński Jan,Cybulski Cezary^ORCID

Funder

Narodowe Centrum Nauki

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-019-05391-w.pdf

Reference18 articles.

1. Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M et al (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372:2243–2257. https://doi.org/10.1056/NEJMsr1501341

2. Muranen TA, Greco D, Blomqvist C, Aittomäki K, Khan S, Hogervorst F, Verhoef S, Pharoah PDP, Dunning AM, Shah M et al (2017) Genetic modifiers of CHEK2*1100delC-associated breast cancer risk. Genet Med 19:599–603. https://doi.org/10.1038/gim.2016.147

3. Rusak B, Kluźniak W, Wokołorczyk D, Stempa K, Kashyap A, Gronwald J, Huzarski T, Dębniak T, Jakubowska A, Masojć B et al (2019) Inherited NBN mutations and prostate cancer risk and survival. Cancer Res Treat 51:1180–1187. https://doi.org/10.4143/crt.2018.532